N-Glycan Analysis: The Cornerstone of Biologic Quality Control

Posted on
by

N-Glycan analysis is a critical quality attribute (CQA) for antibody drugs, directly impacting stability, efficacy, ADCC/CDC activity, half-life, and immunogenicity risk control.

Hyasen Biotech N-Glycan Analysis Kits

Hyasen Biotech provides a complete, ready-to-use N-Glycan analysis solution designed to simplify and accelerate your biologic QC workflow:

  • Ultra-fast workflow: Entire process completed in
  • High-efficiency PNGase F digestion: 5-minute rapid digestion with 100% digestion efficiency for IgG1, IgG4, fusion proteins, and other glycoproteins.
  • Outstanding analytical performance: Excellent repeatability, linearity (R² > 0.99), and batch-to-batch consistency with CV < 10% for key glycoforms.
  • Regulatory & benchmark alignment: Glycan profiles and retention times highly consistent with top imported kits, fully compliant with pharmacopoeia requirements for filing and release.

Empower Your Biologics Development

Backed by robust method validation and real-world customer applications, Hyasen N-Glycan Analysis Kits deliver reliable, sensitive, and time-saving performance for biopharmaceutical R&D and quality control. Partner with Hyasen to enhance efficiency, ensure compliance, and accelerate the development and commercialization of your biologics.

图片1(3) (1).png

Media Contact
Company Name: Hyasen Biotech
Email: Send Email
Country: China
Website: https://www.hyasen.com/